Cathie Wood’s ARK Investment buys 755K shares of Recursion Pharmaceuticals, Inc. (RXRX)
I'm PortAI, I can summarize articles.
Cathie Wood’s ARK Investment has purchased 755,000 shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) on December 19, 2025. Recursion is recognized as one of the 12 Best Genomics Stocks to Invest In. Additionally, on December 17, 2025, JPMorgan upgraded Recursion Pharmaceuticals from Neutral to Overweight, indicating a positive outlook for the company.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments